ATEC Alphatec Holdings Inc

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that Frances Harrison, who has over two decades of regulatory, clinical affairs and quality experience in the medical device industry, has been named the Company's Vice President, Regulatory, Clinical Affairs and Quality.

Ms. Harrison will be responsible for providing overall strategic direction and leadership to Alphatec Spine's global regulatory, clinical affairs and quality assurance programs.

Since 2009, Ms. Harrison held the position of Global Vice President, Regulatory Affairs for Covidien in Boulder, CO. She was responsible for global registrations, regulatory compliance and product labeling for a business unit with more than $1 billion in annual sales.  Prior to Covidien, Ms. Harrison served as the Global Vice President, Regulatory/Clinical Affairs and Quality Compliance at Lumenis, Ltd., a company that sold surgical, ophthalmic and aesthetic laser systems, as well as class II disposable products.  Before working at Lumenis, Ms. Harrison held a series of progressively senior regulatory affairs roles at C.R. Bard, a medical device company that sold products in the vascular, urology, oncology, and surgical specialty markets. 

"We are pleased to have Fran Harrison join Alphatec Spine," said Dirk Kuyper, the Company's President and CEO. "Fran's expertise will provide the necessary leadership in a global regulatory environment in which the path to product approval is becoming less predictable, especially as we bring our innovative products to market, both in the U.S. and internationally."

We believe that Fran's experience will provide us with the necessary leadership with respect to regulatory, clinical affairs and quality, which will help us achieve both our short-term and long-term goals."

About Alphatec Spine

Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, the Company also markets its products in over 50 international markets through its affiliate, Scient'x S.A.S., via a direct salesforce in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa, South America and Latin America. In Asia and Australia, the Company markets its products through its subsidiary, Alphatec Pacific, Inc., and through Scient'x's distributors in China, Korea and Australia. 

The Alphatec Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3520

CONTACT: Michael O'Neill
         Chief Financial Officer
         Alphatec Spine, Inc.
         (760) 494-6746
         investorrelations@alphatecspine.com
         
         Westwicke Partners
         Lynn C. Pieper
         (415) 202-5678
         lynn.pieper@westwicke.com